sEng serves a key role in PE pathogenesis since it decreases circulating levels of TGFβ, a key modulator of angiogenesis (70), inhibiting TGFβ pathway and leading to endothelial dysfunction (71). The gene discussed is TGFB1; the disease is endothelial dysfunction.